DJIA 17,888.35 168.43 0.95%
NASDAQ 5,156.31 47.64 0.93%
S&P 500 2,102.63 22.22 1.07%
market minute promo

Pfizer (NYSE: PFE)

33.62 0.85 (2.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $33.62 2.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.00
Previous Close $32.77
Daily Range $32.80 - $33.73
52-Week Range $28.47 - $36.46
Market Cap $207.5B
P/E Ratio 24.64
Dividend (Yield) $1.12 (3.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 49,300,270
Average Daily Volume 40,422,057
Current FY EPS $2.18




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary

The Path Is Clear for a New Immunotherapy Entrant

The good news keeps piling up for avelumab and its developing duo.

15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference

Dow Jones Industrial Average Surges 168 Points Despite Manufacturing Data

The 4 Stocks That Lifted the Dow on Tuesday

Today's Stocks Driving Success For The Drugs Industry

Pfizer Is At A 'Strategic Crossroads'

Jim Cramer's Top Takeaways: Allergan, Signet Jewelers, Tiffany

5 Top Income Stocks Boosting Their Already Big Payout

Dow Jones Industrial Average Falls 78 Points on Cyber Monday

3 Companies That Could Become Tax Inversion Targets

The Pfizer-Allergan deal may not be the last tax inversion deal we witness. These three companies could also become the target of a U.S.-based buyer.

See More PFE News...

PFE's Top Competitors

PFE $33.62 (2.59%)
Current stock: PFE
JNJ $102.36 (1.11%)
Current stock: JNJ
ROG $56.00 (1.03%)
Current stock: ROG
GSK $40.92 (1.01%)
Current stock: GSK